What percentage of patients have mild tricuspid (tricuspid valve) regurgitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevalence of Mild Tricuspid Valve Regurgitation

Approximately 45% of patients undergoing echocardiography have mild tricuspid regurgitation (TR), making it an extremely common finding in clinical practice. 1

Epidemiology of Tricuspid Regurgitation

Tricuspid regurgitation is one of the most frequently observed valvular abnormalities in clinical practice. The distribution of TR severity based on recent large-scale studies shows:

  • No/trivial TR: 70.9% of patients
  • Mild TR: 21.4-45% of patients
  • Moderate TR: 5.9-15% of patients
  • Severe TR: 1.8-6.5% of patients 1, 2

This prevalence data comes from large echocardiographic databases, with the National Echocardiography Database of Australia study examining 439,558 adults 2 and another comprehensive study analyzing 21,429 consecutive echocardiograms 1.

Clinical Significance of Mild TR

While mild TR has traditionally been considered a benign finding, recent evidence suggests otherwise:

  • Mild TR is independently associated with a 25% increased mortality rate compared to minimal TR (HR 1.25) 1
  • Even after full adjustment for confounding factors (including right ventricular systolic pressure, atrial fibrillation, and left heart disease), mild TR carries a 1.24-fold increased risk of mortality (HR 1.24) 2
  • Mild TR should be considered a marker of disease burden with prognostic implications 1

Factors Associated with TR Presence and Severity

Several factors are associated with the presence and severity of TR:

  • Demographic factors:

    • Advanced age
    • Female gender 3
  • Cardiac factors:

    • Pulmonary hypertension (PASP is a strong determinant)
    • Right atrial and right ventricular enlargement
    • Tricuspid annular dilation
    • Left atrial enlargement
    • Presence of pacemaker leads
    • Organic mitral valve disease 3

Physiologic vs. Pathologic Mild TR

It's important to distinguish between physiologic and pathologic mild TR:

  • Physiologic TR:

    • Present in up to 65-75% of normal individuals
    • Associated with normal valve leaflets
    • No dilation of right ventricle or right atrium
    • Small central jet (<1 cm)
    • Often doesn't extend throughout systole
    • Peak systolic velocities between 1.7-2.3 m/s 4
  • Pathologic mild TR:

    • Associated with structural abnormalities
    • May be primary (affecting valve leaflets) or secondary (functional)
    • More likely to progress over time

Clinical Implications

The presence of mild TR has several important clinical implications:

  • Endocarditis prophylaxis is not recommended for patients with isolated mild TR 4
  • Mild TR may progress over time, especially in patients with tricuspid annular dilation (>40 mm diameter) 4
  • In patients undergoing left-sided valve surgery, concomitant tricuspid valve repair may be beneficial if there is tricuspid annular dilation or prior evidence of right heart failure 4

Conclusion

Mild tricuspid regurgitation is extremely common, affecting approximately 45% of patients undergoing echocardiography. While often considered benign, recent evidence suggests it may be a marker of underlying cardiac disease and is independently associated with increased mortality. Careful assessment of associated factors such as right heart size, pulmonary pressures, and tricuspid annular dimensions is important for proper risk stratification.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.